An updated version of a blood screening assay that detects human immunodeficiency virus type 1 (HIV-1), hepatitis C virus (HCV), and hepatitis B virus... More »
SAN FRANCISCO – Patients with metastatic colorectal cancer fared better if they had higher pretreatment levels of vitamin D, according to a prospective analysis from a phase III trial.
On average,...
Gilead Sciences Inc. and Aetna Inc. have announced a partnership wherein the drug company will offer Aetna’s approximately 20 million health plan me... More »
CHICAGO – Portal vein recanalization using a transsplenic approach can be utilized to improve transplant candidacy in patients with cirrhosis and ch... More »
The recent advent of new treatments for hepatitis C prompted organizations including the Centers for Disease Control and Prevention, the U.S. Preventi... More »
The way in which microbial communities are organized in the mucosa of the colon could be a critical factor in the development of some colorectal cancers, researchers said.
The presence of bacterial...
ORLANDO – Studies with small patient populations but large effect sizes are the backbone of an independent investigator’s success. Rigorous patient selection doesn’t hurt, either.
“We often hide...
Gilead Sciences Inc. scored an exclusive deal with CVS Health Corp., as its two hepatitis C medicines, Harvoni and Sovaldi, will be available only for CVS customers.
Sovaldi costs $84,000 for a...
ORLANDO – Independent investigators eager to author studies that have notable impact on the field of inflammatory bowel disease have plenty of impor... More »
Sofosbuvir and ribavirin treatments should be administered to patients with hepatitis C virus who undergo liver transplantations in order to significantly decrease the risks of posttransplant HCV...
